Janice Schakowsky actually said...
At the very least, there could be more transparency about the way these funds are flowing.
Context
Calls for transparency in pharmaceutical pricing and funding.
05/20/2019
Calls for transparency in pharmaceutical pricing and funding.
05/20/2019